CTMT212X2102: Phase I, Open-Label Study to Determine the Effect of Repeat Dosing of Trametinib on the Pharmacokinetics of a Combined Oral Contraceptive (Norethindrone plus Ethinyl Estradiol) in Female Patients with Solid Tumors

February 17, 2019
https://clinicaltrials.gov/ct2/results?id=NCT02705963
Solid Tumors, Cancer - Gastro/ Esophageal, Cancer - Genitourinary/ Bladder
Principal Investigator: Ding Wang, MD
Cancer, Esophageal, Esophageal Cancer, Solid Tumors, Phase I, Phase 1, Oral, Oral contraceptive, Female, Gallbladder, Bladder Cancer, Bladder
Open